Discontinued — last reported Q2 '24
Software as a Service — Operating Income (Loss)
ResMed Software as a Service — Operating Income (Loss) remained flat by 0.0% to $38.61M in Q2 2024 compared to the prior quarter. Year-over-year, this metric grew by 33.7%, from $28.88M to $38.61M. Over 3 years (FY 2021 to FY 2024), Software as a Service — Operating Income (Loss) shows an upward trend with a 18.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher operating income indicates improved pricing power, operational leverage, or cost management within the digital services division.
Detailed definition
This represents the profitability of the Software as a Service segment after deducting operating expenses from net reven...
Peer comparison
Commonly reported as segment operating profit in diversified healthcare and technology firms.
rmd_segment_software_as_a_service_operating_income_lossHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $92.36M | $93.04M | $115.53M | $154.45M |
| YoY Change | — | +0.7% | +24.2% | +33.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is ResMed's software as a service — operating income (loss)?
- ResMed (RMD) reported software as a service — operating income (loss) of $38.61M in Q2 2024.
- How has ResMed's software as a service — operating income (loss) changed year-over-year?
- ResMed's software as a service — operating income (loss) increased by 33.7% year-over-year, from $28.88M to $38.61M.
- What is the long-term trend for ResMed's software as a service — operating income (loss)?
- Over 3 years (2021 to 2024), ResMed's software as a service — operating income (loss) has grown at a 18.7% compound annual growth rate (CAGR), from $92.36M to $154.45M.
- What does software as a service — operating income (loss) mean?
- The profit or loss generated specifically by the SaaS business segment before interest and taxes.